AbbVie registers Phase 1 trial comparing upadacitinib, tofacitinib, baricitinib in healthy adultsSep 30Weekly roundup, 4 itemsABBV-722AbbVie
Boehringer Ingelheim registers Phase Ib/II trial pairing obrixtamig, pumitamig in SCLCSep 28Trial updateBioNTech SEBoehringer Ingelheim
Summit's partner Akeso reports positive Phase III data for ivonescimab in bile duct cancerAug 26Clinical readoutivonescimabSummit Therapeutics
Actuate-linked trial of 9-ING-41 plus carboplatin in salivary gland cancer posts resultsAug 7Trial updateActuate Therapeutics Inc.pemetrexed
ROCKIF trial of defactinib in ovarian cancer terminated for lost funding; results postedJul 31Trial updatedefactinibVerastem, Inc.
BMS posts PRIME-HCC results; adds SOTYKTU label update, Phase 3 lung trialJul 2Weekly roundup, 7 itemsBristol Myers Squibbcisplatin
Sign inSign in